BChE Antibodies

Santa Cruz Biotechnology provides a broad selection of BChE Antibodies for studying butyrylcholinesterase, an important enzyme involved in the hydrolysis of choline esters. BChE Antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Butyrylcholinesterase plays a critical role in the regulation of neurotransmission and is involved in the metabolism of certain drugs and toxins. Its activity is essential for maintaining cholinergic signaling and has implications in neurodegenerative diseases, drug metabolism, and pesticide exposure. Understanding the function and regulation of butyrylcholinesterase is crucial for advancing therapeutic strategies and improving patient outcomes. BChE monoclonal antibodies enable detailed investigation of enzyme distribution, activity levels, and molecular interactions in various biological systems. Researchers can effectively track butyrylcholinesterase expression patterns across different tissues and experimental conditions. Current research utilizing BChE monoclonal antibodies contributes significantly to neuroscience, toxicology, and drug development studies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of butyrylcholinesterase's role in health and disease.